OH_Logo.png
Optimi Health and Numinus Wellness Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application
May 11, 2021 09:00 ET | Optimi Health Corp.
VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...
OH_Logo.png
Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol
May 04, 2021 09:00 ET | Optimi Health Corp.
VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...
OH_Logo.png
Optimi Health Finalizes Planned Build-Out of Mushroom Production and Research Facility
April 27, 2021 09:00 ET | Optimi Health Corp.
VANCOUVER, British Columbia, April 27, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...
OH_Logo.png
Optimi Health Adds to Corporate and Advisory Team
April 14, 2021 09:00 ET | Optimi Health Corp.
VANCOUVER, British Columbia, April 14, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...
OH_Logo.png
Optimi Health Aims to Expand its Shareholder Base
April 06, 2021 09:30 ET | Optimi Health Corp.
VANCOUVER, British Columbia, April 06, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom...
Optimi Health Large Scale Multi-Purpose Mushroom Facility Advances Towards Completion and Licensing
March 23, 2021 09:00 ET | Optimi Health Corp.
VANCOUVER, British Columbia, March 23, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused...
OH_Logo.png
Optimi Health Receives Health Canada NPN Product Licenses in Preparation for Q2 Sales Launch
March 16, 2021 09:00 ET | Optimi Health Corp.
--Company Introduces Celebrity Wellness Expert Harley Pasternak as Advisor VANCOUVER, British Columbia, March 16, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (“Optimi” or the...
OH_Logo.png
Optimi Health Accelerates Psilocybin Clinical Trial Program with IMPACT
March 09, 2021 09:00 ET | Optimi Health Corp.
VANCOUVER, British Columbia, March 09, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused...
OH_Logo.png
OPTIMI HEALTH and NUMINUS WELLNESS to Conduct Psychedelic Lab Research and Development
March 02, 2021 09:00 ET | Optimi Health Corp.
Agreement propels development of safe and effective proprietary products and formulations for the emerging psychedelic industry VANCOUVER, British Columbia, March 02, 2021 (GLOBE NEWSWIRE) --...
OH_Logo.png
Optimi Health Corp. Completes Oversubscribed $20.7 Million Initial Public Offering, and Announces Listing on the CSE
February 25, 2021 09:00 ET | Optimi Health Corp.
NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (“Optimi” or the...